publication date: Oct. 1, 2015
NCI CTEP-Approved Trials For the Month of September
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month. For further information, contact the principal investigator listed.
9834: A Phase I Study of Methoxyamine Combined with Chemo-Radiation for Locally Advanced Non-Squamous Non-Small Cell Lung Cancer. Case Western Reserve University; Biswas, Tithi. (216) 286-6740
9874: A Phase I Trial of AT13387 in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) Receiving Concurrent Radiation and Cisplatin. University Health Network Princess Margaret Cancer Center LAO; Hope, Andrew J. (416) 946-2124
ADVL1416: A Phase 1 Study of Ramucirumab, a Human, Monoclonal Antibody Against the Vascular Endothelial Growth Factor-2 (VEGFR-2) Receptor in Children with Refractory Solid Tumors, Including CNS Tumors. COG Phase 1 Consortium; Pradhan, Kamnesh. (317) 944-8784
9837: Phase I Study of TRC102 in Combination with Cisplatin and … Continue reading CCL Sept – NCI CTEP-Approved Trials For the Month of September
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.